• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prevalence and treatment of familial hypercholesterolaemia in Australian communities.

作者信息

Watts Gerald F, Shaw Jonathan E, Pang Jing, Magliano Dianna J, Jennings Garry L R, Carrington Melinda J

机构信息

School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia; Lipid Disorders Clinic, Cardiometabolic Service, Royal Perth Hospital, Perth, Western Australia, Australia.

Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.

出版信息

Int J Cardiol. 2015 Apr 15;185:69-71. doi: 10.1016/j.ijcard.2015.03.027. Epub 2015 Mar 3.

DOI:10.1016/j.ijcard.2015.03.027
PMID:25791093
Abstract
摘要

相似文献

1
Prevalence and treatment of familial hypercholesterolaemia in Australian communities.澳大利亚社区家族性高胆固醇血症的患病率及治疗情况
Int J Cardiol. 2015 Apr 15;185:69-71. doi: 10.1016/j.ijcard.2015.03.027. Epub 2015 Mar 3.
2
Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication.丹麦普通人群中的家族性高胆固醇血症：患病率、冠心病和降胆固醇药物。
J Clin Endocrinol Metab. 2012 Nov;97(11):3956-64. doi: 10.1210/jc.2012-1563. Epub 2012 Aug 14.
3
Prevalence of DNA-confirmed familial hypercholesterolaemia in young patients with myocardial infarction.经DNA确认的家族性高胆固醇血症在年轻心肌梗死患者中的患病率。
Eur J Intern Med. 2015 Mar;26(2):127-30. doi: 10.1016/j.ejim.2015.01.014. Epub 2015 Feb 11.
4
Familial hypercholesterolaemia: clinical features and management.家族性高胆固醇血症：临床特征与管理
Nurs Stand. 2005;20(14-16):55-65; quiz 66. doi: 10.7748/ns2005.12.20.14.55.c4029.
5
Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery disease.米泊美生抑制载脂蛋白 B 合成治疗杂合子家族性高胆固醇血症：一项评估其在冠状动脉疾病患者中的附加治疗疗效和安全性的随机、双盲、安慰剂对照试验结果。
Circulation. 2012 Nov 6;126(19):2283-92. doi: 10.1161/CIRCULATIONAHA.112.104125. Epub 2012 Oct 11.
6
Familial hypercholesterolaemia in Australia: new insights and developments.澳大利亚的家族性高胆固醇血症：新见解与新进展
Med J Aust. 2013 Feb 4;198(2):72-3. doi: 10.5694/mja12.11467.
7
Familial hypercholesterolaemia: new treatment options.家族性高胆固醇血症：新的治疗选择。
Neth J Med. 2013 Jun;71(5):227-33.
8
Anacetrapib in familial hypercholesterolaemia: pros and cons.阿那曲匹用于家族性高胆固醇血症：利弊分析
Lancet. 2015 May 30;385(9983):2124-6. doi: 10.1016/S0140-6736(14)62315-1. Epub 2015 Mar 3.
9
[Polyphepan (lignin) as an hypocholesteremic agent].[聚酚磺醛（木质素）作为一种降胆固醇药物]
Klin Med (Mosk). 1987 Jul;65(7):48-52.
10
Coronary artery bypass grafting in familial hypercholesterolemia.家族性高胆固醇血症的冠状动脉搭桥术
J Thorac Cardiovasc Surg. 1995 Feb;109(2):364-9. doi: 10.1016/S0022-5223(95)70398-5.

引用本文的文献

1
The alasian alth and Welleing ssessmen (MyHEBAT) Study Protocol: An Initiation of a National Registry for Extended Cardiovascular Risk Evaluation in the Community.亚洲心脏与健康评估（MyHEBAT）研究方案：社区开展的全国心血管扩展风险评估登记研究。
Int J Environ Res Public Health. 2022 Sep 19;19(18):11789. doi: 10.3390/ijerph191811789.
2
Familial hypercholesterolaemia and coronary risk factors among patients with angiogram-proven premature coronary artery disease in an Asian cohort.家族性高胆固醇血症与亚洲队列中经血管造影证实的早发性冠心病患者的冠状动脉危险因素。
PLoS One. 2022 Sep 2;17(9):e0273896. doi: 10.1371/journal.pone.0273896. eCollection 2022.
3
Integrated guidance to enhance the care of children and adolescents with familial hypercholesterolaemia: Practical advice for the community clinician.
综合指导以加强家族性高胆固醇血症患儿和青少年的照护：社区临床医生的实用建议。
J Paediatr Child Health. 2022 Aug;58(8):1297-1312. doi: 10.1111/jpc.16096. Epub 2022 Jul 15.
4
Familial Hypercholesterolemia and Elevated Lipoprotein(a): Cascade Testing and Other Implications for Contextual Models of Care.家族性高胆固醇血症与脂蛋白(a)升高：级联检测及对情境化照护模式的其他影响
Front Genet. 2022 Apr 27;13:905941. doi: 10.3389/fgene.2022.905941. eCollection 2022.
5
Using electronic medical record data to assess chronic kidney disease, type 2 diabetes and cardiovascular disease testing, recognition and management as documented in Australian general practice: a cross-sectional analysis.利用电子病历数据评估澳大利亚全科医疗中慢性肾脏病、2 型糖尿病和心血管疾病的检测、识别和管理情况：一项横断面分析。
Fam Med Community Health. 2022 Feb;10(1). doi: 10.1136/fmch-2021-001006.
6
Familial Hypercholesterolemia in Asia Pacific: A Review of Epidemiology, Diagnosis, and Management in the Region.亚太地区家族性高胆固醇血症：该地区流行病学、诊断和管理的综述。
J Atheroscler Thromb. 2021 May 1;28(5):417-434. doi: 10.5551/jat.56762. Epub 2021 Mar 19.
7
Validity and reliability of an adapted questionnaire measuring knowledge, awareness and practice regarding familial hypercholesterolaemia among primary care physicians in Malaysia.马来西亚基层医疗医生家族性高胆固醇血症知识、意识和实践调查问卷的适用性、信度和效度。
BMC Cardiovasc Disord. 2021 Jan 19;21(1):39. doi: 10.1186/s12872-020-01845-y.
8
Familial Hypercholesterolaemia in the Malaysian Community: Prevalence, Under-Detection and Under-Treatment.马来西亚社区的家族性高胆固醇血症：患病率、漏诊率和治疗不足。
J Atheroscler Thromb. 2021 Oct 1;28(10):1095-1107. doi: 10.5551/jat.57026. Epub 2021 Jan 15.
9
Screening for potential familial hypercholesterolaemia in general practice: an observational study on prevalence and management.在全科医疗中筛查潜在的家族性高胆固醇血症：一项关于患病率及管理的观察性研究
BJGP Open. 2021 Apr 26;5(2). doi: 10.3399/bjgpopen20X101142. Print 2021 Apr.
10
Targeted Genetic Analysis in a Chinese Cohort of 208 Patients Related to Familial Hypercholesterolemia.中国 208 例家族性高胆固醇血症患者的靶向基因分析。
J Atheroscler Thromb. 2020 Dec 1;27(12):1288-1298. doi: 10.5551/jat.54593. Epub 2020 Aug 6.